This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Ab. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Martin O Savage: Innovator in the Field of IGF-1
Introduction
Martin O Savage is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly through his work involving insulin-like growth factor 1 (IGF-1). With a focus on innovative solutions, he has secured a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Martin O Savage holds a patent related to the use of IGF-1. This patent reflects his commitment to exploring the therapeutic potential of this important growth factor in various medical applications. His innovative approach has the potential to impact treatments and improve patient outcomes.
Career Highlights
Throughout his career, Martin has been associated with Pharmacia AB, a company known for its contributions to pharmaceuticals and biotechnology. His role at Pharmacia AB has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Martin has worked alongside esteemed colleagues such as David B Dunger and Peter Henri Sonksen. These collaborations have enriched his research and expanded the scope of his work in the field of IGF-1.
Conclusion
In summary, Martin O Savage is a distinguished inventor whose work on IGF-1 has the potential to transform medical treatments. His contributions to the field, along with his collaborations, highlight his importance in the realm of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile